Form 4: Amkor Technology CEO Guillaume Rutten Executes Stock Option and Sells Shares
SEC Form 4 Filing
Amkor Technology's CEO, Guillaume Rutten, exercised stock options and sold a portion of the acquired shares on September 16, 2024, according to a recent SEC filing.
Summary
- On September 16, 2024, Guillaume Rutten, the President and CEO of Amkor Technology, Inc., exercised stock options to acquire 8,125 shares of common stock at a price of $14.17 per share.
- Simultaneously, Rutten sold 18,125 shares of Amkor Technology common stock at $30 per share.
- Following these transactions, Rutten directly owns 214,971 shares of Amkor Technology common stock.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 28, 2024.
- Rutten also holds options to acquire 375,000 shares, granted on July 30, 2020, which vested in equal quarterly installments over three years.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of insider trading activity under a pre-arranged plan. It doesn't inherently indicate positive or negative prospects for the company.
Industry Context
This filing is a routine disclosure of insider transactions. It's common for executives to exercise stock options and sell shares, often under pre-arranged trading plans to avoid accusations of insider trading. The market will likely interpret this as a standard transaction unless the volume is unusually high or accompanied by other significant news.
Comparison to Industry Standards
- Executive compensation packages in the semiconductor industry often include stock options as a significant component.
- Companies like Texas Instruments (TXN) and Intel (INTC) also have executives who regularly exercise options and sell shares.
- The use of Rule 10b5-1 trading plans is a common practice among executives to manage their stock transactions in a transparent and compliant manner.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders.
- Shareholders may see it as a routine event.
- Employees are unlikely to be directly affected.
Key Dates
| Date | Description |
|---|---|
| 07/30/2020 | Grant date of employee stock option to acquire 375,000 shares. |
| 10/30/2020 | First date employee stock options were exercisable. |
| 05/28/2024 | Date the Reporting Person adopted a Rule 10b5-1 trading plan. |
| 09/16/2024 | Date of stock option exercise and stock sale. |
| 09/18/2024 | Date of Form 4 filing. |
| 07/30/2030 | Expiration date of employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.